New from NCI |
How Imatinib Transformed Leukemia Treatment and Cancer Research |
![artistic rendering of DNA strands](https://blogger.googleusercontent.com/img/proxy/AVvXsEiD-L0zLuzRtv6sqjXecCpkfqcbKE_PyVBQl1TpBPtiZofKX917rKIUO5-1frxtu9ab9IAZJ2xU-b0Mb2zOy18skijMY_yti3l5thMN8ITZ019ya4_oJ5GUvYRAWfFipDFMqnJi_AgF96JWiSGEQwOHrB7JkFkIXzNUTg9_C2G3a3xj_bPE1Etni-WOoTnDvdx0TBAndh2JAKXEDqpgf3RiQb-Uxn8GzvGHtXiFU3dDq1SNZ8I1N-jM1Q=s0-d-e1-ft) | | Learn about the NCI-supported discoveries that led to the development of imatinib (Gleevec). These discoveries helped establish a new group of drugs known as targeted therapy that has changed the treatment of cancer. |
Video—Introduction to Adolescent and Young Adult Cancers |
![AYA Video Screen Shot](https://blogger.googleusercontent.com/img/proxy/AVvXsEhPfVzKSz_foKbEwWaS8tdgvTjYkXiX6KO-cYS6fMcTrVH7nULypYBe3J95N0MOAHLk60oMvUJ72kNQj9lhD__qiSHaChjgYD6ygwVYSaWlRSkjSzoqJpdcNYWefmZ-KNEVBApuh4mpACMWfoe_q6nYxHaB146QiopsQT9jNlP81AAKBdrSG11oTdwoU_QBCOAox4v2s9jPxlHR75kDNq7u9AWML3hwBqPPer3djXdrdj1EMhrk_AexMzuc=s0-d-e1-ft) | | This video covers basic facts about cancer in adolescents and young adults and discusses the unique challenges these patients face. |
Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers
Scientists have struggled to come up with a simple test to detect endometrial and ovarian cancers early, when they are most likely to respond to treatment. Can a liquid biopsy test called PapSEEK change that? |
Immunotherapy Drugs Expand Treatment Options for Advanced Lung Cancer |
![Immune checkpoint inhibitor monoclonal antibodies (Ab) that block PD-1 proteins target immune cells in the lymph nodes and immune and cancer cells in tumors.](https://blogger.googleusercontent.com/img/proxy/AVvXsEg2V4HSYjJN6SIVFURI-I2XiXe3uKdrYOeHwQO83PcUbl4jQAcijoD72rSHLgi9YP_mefpV49gWzjOxhYjc2V4YpQ_swg48BHi4nYRSj5o_iqz741Is-y6Vm9p8rwVm5kMmPYgsfQyLuzT3Nu7Uo6wFQFXE8IxXMx-RaGToS2iDNsd4QUKQA5VpoeWm0BAqgncpyLdr0y1w29tsqL3D30p_b0rjXbaEcxTONCfMYuqKUb3yDE77VB4G9oBguQ=s0-d-e1-ft) | | Results from a large clinical trial testing a combination of the immunotherapy pembrolizumab (Keytruda) and chemotherapy in patients newly diagnosed with metastatic lung cancer may change clinical practice. |
Does Muscle Mass Affect Cancer Survival?
Read about a recent study in which researchers measured muscle mass in women with breast cancer and tracked its connection to survival. |
New Option for Women with Recurrent Ovarian Cancer
The Food and Drug Administration (FDA) recently approved a new PARP inhibitor for women with ovarian cancer who meet certain criteria. Learn about PARP inhibitors and why they are helpful in treating this disease. |
PDQ Summary Updates |
Non-Small Cell Lung Cancer Treatment
We’ve revised our PDQ summary on non-small cell lung cancer (NSCLC) with updates to the tests used to diagnose and stage the disease and to the treatments used for different stages. |
Drug Information Updates |
Ipilimumab Approved for Kidney Cancer
We’ve updated our drug information summary with a recent FDA approval. Ipilimumab (Yervoy) is now approved to be used with nivolumab to treat renal cell carcinoma, which is a type of kidney cancer. |
Nivolumab Combination in Kidney Cancer
Our updated drug information summary on nivolumab (Opdivo) includes the FDA’s recent approval of the drug for use with ipilimumab as a first-line therapy for renal cell carcinoma. |
Osimertinib Use in Lung Cancer
We’ve updated our drug information summary to include FDA’s expanded approval for osimertinib (Tagrisso) in NSCLC. The drug is now approved as a first-line treatment in certain patients with metastatic NSCLC. |
Tocilizumab for Cytokine Release Syndrome
We've added a new drug summary for tocilizumab (Actemra), which was approved by FDA to treat cytokine release syndrome (CRS) caused by CAR T-cell therapy. CRS is a severe side effect that can occur with some types of immunotherapy. |
No hay comentarios:
Publicar un comentario